134 related articles for article (PubMed ID: 38057559)
1. Real-world experience of implementing the MOLES score in a virtual choroidal naevi clinic at a tertiary referral centre.
Rees NOT; Schimansky S; Bizley G; Kobayter L
Eye (Lond); 2024 Apr; 38(6):1183-1188. PubMed ID: 38057559
[TBL] [Abstract][Full Text] [Related]
2. The MOLES system to guide the management of melanocytic choroidal tumours: can optometrists apply it?
Flanagan JP; O'Day RF; Roelofs KA; McGuinness MB; van Wijngaarden P; Damato BE
Clin Exp Optom; 2023 Apr; 106(3):271-275. PubMed ID: 35156536
[TBL] [Abstract][Full Text] [Related]
3. Estimating malignancy risk of melanocytic choroidal tumours detected in the Australian National Eye Health Survey.
Salehi O; van Wijngaarden P; Keel S; Foreman J; Dirani M; Damato B; O'Day R
Clin Exp Optom; 2021 Nov; 104(8):854-858. PubMed ID: 33689655
[No Abstract] [Full Text] [Related]
4. Can the MOLES acronym and scoring system improve the management of patients with melanocytic choroidal tumours?
Damato BE
Eye (Lond); 2023 Apr; 37(5):830-836. PubMed ID: 35764877
[TBL] [Abstract][Full Text] [Related]
5. Naevi Characterization Using Hyperspectral Imaging: A Pilot Study.
Selvander M; Alexander J; Guenot D
Curr Eye Res; 2024 Jun; 49(6):624-630. PubMed ID: 38407145
[TBL] [Abstract][Full Text] [Related]
6. Distinguishing Choroidal Nevi from Melanomas Using the MOLES Algorithm: Evaluation in an Ocular Nevus Clinic.
Al Harby L; Sagoo MS; O'Day R; Hay G; Arora AK; Keane PA; Cohen VM; Damato B
Ocul Oncol Pathol; 2021 Sep; 7(4):294-302. PubMed ID: 34604203
[TBL] [Abstract][Full Text] [Related]
7. Is Tumour Thickness Measurement Required for MOLES Scoring of Melanocytic Choroidal Tumours?
Ching J; AlHarby L; Sagoo MS; Damato B
Ocul Oncol Pathol; 2023 Aug; 9(1-2):40-47. PubMed ID: 38376089
[TBL] [Abstract][Full Text] [Related]
8. Detecting Progression of Melanocytic Choroidal Tumors by Sequential Imaging: Is Ultrasonography Necessary?
Roelofs KA; O'Day R; Al Harby L; Hay G; Arora AK; Cohen VML; Sagoo MS; Damato BE
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32664236
[No Abstract] [Full Text] [Related]
9. Prospective validation of a virtual clinic pathway in the management of choroidal naevi: the NAEVUS study Report no. 1: safety assessment.
Al Harby L; Ali Z; Rajai A; Roberts SA; Peto T; Leung I; Gray J; Hay G; Arora AK; Keane PA; Cohen VML; Sagoo M; Balaskas K
Br J Ophthalmol; 2022 Jan; 106(1):128-134. PubMed ID: 33037007
[TBL] [Abstract][Full Text] [Related]
10. Ocular pigmented findings in patients with dysplastic naevus syndrome.
Toth-Molnar E; Olah J; Dobozy A; Hammer H
Melanoma Res; 2004 Feb; 14(1):43-7. PubMed ID: 15091193
[TBL] [Abstract][Full Text] [Related]
11. Optical Density Ratio of Subretinal Fluid in Choroidal Melanomas Versus Choroidal Naevi Assessed by Optical Coherence Tomography.
Mahoun Z; Malaise D; Lumbroso-Le Rouic L; Levy-Gabriel C; Cassoux N; Matet A
Invest Ophthalmol Vis Sci; 2023 Oct; 64(13):1. PubMed ID: 37788003
[TBL] [Abstract][Full Text] [Related]
12. The advantages of intermediate-tier, inter-optometric referral of low risk pigmented lesions.
Ly A; Nivison-Smith L; Hennessy M; Kalloniatis M
Ophthalmic Physiol Opt; 2017 Nov; 37(6):661-668. PubMed ID: 29044669
[TBL] [Abstract][Full Text] [Related]
13. The MOLES System for Planning Management of Melanocytic Choroidal Tumors: Is It Safe?
Roelofs KA; O'Day R; Harby LA; Arora AK; Cohen VML; Sagoo MS; Damato B
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32455720
[TBL] [Abstract][Full Text] [Related]
14. High naevus count and MC1R red hair alleles contribute synergistically to increased melanoma risk.
Duffy DL; Lee KJ; Jagirdar K; Pflugfelder A; Stark MS; McMeniman EK; Soyer HP; Sturm RA
Br J Dermatol; 2019 Nov; 181(5):1009-1016. PubMed ID: 30820946
[TBL] [Abstract][Full Text] [Related]
15. Survey of ophthalmic imaging use to assess risk of progression of choroidal nevus to melanoma.
DeSimone JD; Dockery PW; Kreinces JB; Soares RR; Shields CL
Eye (Lond); 2023 Apr; 37(5):953-958. PubMed ID: 35606548
[TBL] [Abstract][Full Text] [Related]
16. Management of choroidal naevomelanocytic lesions: feasibility and safety of a virtual clinic model.
Balaskas K; Gray J; Blows P; Rajai A; Flaye D; Peto T; Sagoo MS
Br J Ophthalmol; 2016 May; 100(5):665-70. PubMed ID: 26347525
[TBL] [Abstract][Full Text] [Related]
17. [Risk factors for the degeneration of the choroid naevi: a retrospective study of 135 cases].
Desjardins L; Lumbroso L; Levy C; Plancher C; Asselain B
J Fr Ophtalmol; 2001 Jun; 24(6):610-6. PubMed ID: 11460057
[TBL] [Abstract][Full Text] [Related]
18. Features of choroidal naevi on swept source optical coherence tomography angiography and structural reverse flow optical coherence tomography.
Ali ZC; Gray J; Balaskas K
Graefes Arch Clin Exp Ophthalmol; 2018 Jul; 256(7):1319-1323. PubMed ID: 29520479
[TBL] [Abstract][Full Text] [Related]
19. 'Mind your Moles' study: protocol of a prospective cohort study of melanocytic naevi.
Koh U; Janda M; Aitken JF; Duffy DL; Menzies S; Sturm RA; Schaider H; Betz-Stablein B; Prow T; Soyer HP; Green AC
BMJ Open; 2018 Sep; 8(9):e025857. PubMed ID: 30232117
[TBL] [Abstract][Full Text] [Related]
20. Subclinical subretinal fluid detectable only by optical coherence tomography in choroidal naevi-the SON study.
Fung AT; Guan R; Forlani V; Li YC; Chhablani J; Maltsev DS; Zur D; Iglicki M; Couturier A; Shinojima A; Almeida AC; Busch C; Lupidi M; Cagini C; Rishi P; Gabrielle PH; Fraser-Bell S; Amphornphruet A; Chotcomwongse P; Chen YH; Pellegrini M;
Eye (Lond); 2021 Jul; 35(7):2038-2044. PubMed ID: 33057241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
